Heron Therapeutics Announces FDA Approval OF Indication expansion For ZYNRELEF ; ZYNRELEF Now Indicated In Adults For Soft Tissue Or Periarticular Instillation To Produce Postsurgical Analgesia For Up To 72 Hours After Certain Procedures

by | Dec 9, 2021 | Extra Jobs | 0 comments

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.